Use of clobetasol in lacquer for plaque psoriasis treatment

dc.creatorSilva
dc.creatorSuze Aparecida da; Magalhães
dc.creatorRenata Ferreira; Torres
dc.creatorRafael Augusto Tamasauskas; Oliveira
dc.creatorRaquel Diana de; Velho
dc.creatorPaulo Eduardo Neves Ferreira
dc.date2016
dc.date2016-11-10T19:22:36Z
dc.date2016-11-10T19:22:36Z
dc.date.accessioned2018-03-29T01:59:02Z
dc.date.available2018-03-29T01:59:02Z
dc.identifierAnais Brasileiros De Dermatologia, 91, 1, p.113-. 2016.
dc.identifier1806-4841
dc.identifierS0365-05962016000100113
dc.identifier10.1590/abd1806-4841.20164228
dc.identifierhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000100113
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/318878
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1309760
dc.descriptionClobetasol benefits to control psoriasis lesions are well defined, but there were not studies about its action when used in lacquer vehicle to control skin lesions. A double-blind study was conducted with 40 patients that utilized clobetasol 0.05% in one hemibody and just the vehicle in the other hemibody. Twenty of them used petrolatum as vehicle and the others used lacquer. An assessment was conducted using the clinical index PASI and a quality of life questionnaire (Dermatological Life Quality Index). There was no statistical difference between groups. There was a trend of favorable response particularly in the hemibody treated with clobetasol.
dc.description
dc.description91
dc.description1
dc.description113
dc.description115
dc.languageEnglish
dc.relationAnais Brasileiros de Dermatologia
dc.relationAnais Brasileiros de Dermatologia
dc.rightsaberto
dc.sourceSciELO
dc.titleUse of clobetasol in lacquer for plaque psoriasis treatment
dc.title
dc.typerapid-communication


Este ítem pertenece a la siguiente institución